Methods Of Treating Inflammatory And Autoimmune Diseases With Natalizumab

Patent No. EP1991267 (titled "Methods Of Treating Inflammatory And Autoimmune Diseases With Natalizumab") was filed by Biogen Idec MA on Mar 2, 2007. The application was issued on Dec 20, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
PHARMACEUTICAL WORKS POLPHARMASep 20, 2018WICHMANN

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP1991267

BIOGEN IDEC MA
Application Number
EP07751993A
Filing Date
Mar 2, 2007
Status
Revoked
Oct 15, 2021
Publication Date
Dec 20, 2017